Aisha Mobashar
Impact in
-
- Pharmacological Effects of Natural Compounds
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Pharmacological Effects of Natural Compounds 7
- Pharmacological Effects of Medicinal Plants 3
- Co-authors
- Arham Shabbir (16 shared papers)Muhammad Shahzad (8 shared papers)Saman Sargazi (3 shared papers)Abbas Rahdar (3 shared papers)Narges Ebrahimi (2 shared papers)George Z. Kyzas (2 shared papers)Seyedeh Maryam Hosseinikhah (1 shared paper)Simge Er Zeybekler (1 shared paper)
- Journals
- ACS Omega (3 papers)Evidence-based Complementary and Alternative Medicine (3 papers)Respiratory Physiology & Neurobiology (2 papers)Inflammopharmacology (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- PakistanSaudi ArabiaMorocco
In The Last Decade
Aisha Mobashar
24 papers receiving 316 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 31
- Biomaterials 48
- Toxicology 11
- Complementary and alternative medicine 23
- Pharmaceutical Science 15
Countries citing papers authored by Aisha Mobashar
This map shows the geographic impact of Aisha Mobashar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisha Mobashar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisha Mobashar more than expected).
Fields of papers citing papers by Aisha Mobashar
This network shows the impact of papers produced by Aisha Mobashar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisha Mobashar. The network helps show where Aisha Mobashar may publish in the future.
Co-authors
The 25 scholars most cited alongside Aisha Mobashar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 59 | |
| 2 | 2023 | 48 | |
| 3 | 2021 | 34 | |
| 4 | 2022 | 19 | |
| 5 | 2020 | 18 | |
| 6 | 2019 | 16 | |
| 7 | 2022 | 16 | |
| 8 | 2024 | 15 | |
| 9 | 2023 | 12 | |
| 10 | 2021 | 11 | |
| 11 | 2023 | 11 | |
| 12 | 2020 | 11 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 8 | |
| 15 | 2023 | 8 | |
| 16 | 2023 | 7 | |
| 17 | 2025 | 5 | |
| 18 | 2024 | 4 | |
| 19 | Anti-inflammatory effects of Trigonella gharuensis: Comparative analysis in BALB/C mouse model. | 2019 | 3 |
| 20 | 2023 | 3 |
About Aisha Mobashar
Aisha Mobashar is a scholar working on Pharmacology, Pharmacology, Complementary and alternative medicine, Endocrinology, Diabetes and Metabolism and Dermatology, having authored 31 papers that have together received 324 indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (7 papers), Natural product bioactivities and synthesis (5 papers), Natural Antidiabetic Agents Studies (4 papers), Phytochemistry and Bioactive Compounds (3 papers), Dermatology and Skin Diseases (3 papers), Pharmacological Effects of Medicinal Plants (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Pharmacology (31 citations), Biomaterials (48 citations), Toxicology (11 citations), Complementary and alternative medicine (23 citations) and Pharmaceutical Science (15 citations). Aisha Mobashar has collaborated with scholars based in Pakistan, Saudi Arabia and Morocco. Frequent co-authors include Arham Shabbir, Muhammad Shahzad, Saman Sargazi, Abbas Rahdar, Narges Ebrahimi, George Z. Kyzas, Seyedeh Maryam Hosseinikhah, Simge Er Zeybekler, Muhammad Bilal and Ali Salari Sharif. Their work appears in journals such as ACS Omega, Evidence-based Complementary and Alternative Medicine, Respiratory Physiology & Neurobiology, Inflammopharmacology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.